tbuckley/cabot-search huggingface dataset:
Early Detection of Immune-Dysregulation Predicts a Better Response to Immunosuppressive Treatment in Chronic Immune Thrombocytopenia
Authors: Elena Palmisani, Gianluca Dell'Orso, Erica Del Bò, Mariacarla Giarratana, Luca Arcuri, Daniela Guardo, Francesca Bagnasco, Alice Grossi, Marina Lanciotti, Paola Terranova, Carlo Dufour, Francesca Fioredda, Maurizio Miano
Journal: Blood (2024)
Thromboembolism in Individuals with High-Oxygen-Affinity Hemoglobins - Systematic Review of the Literature
Authors: Marie Laloi, Agathe Gouband, Damien Luque-Paz, Marianne Schwarz, Aline Schmidt, Valerie Ugo, Hunault-Berger Mathilde, Loic Garcon, Corentin Orvain
Journal: Blood (2024)
Long-Term Survival of Patients with Relapsed/Refractory Acute Leukemia Receiving Clofarabine/Cyclophosphamide Prior to Hematopoietic Stem Cell Transplantation
Authors: Irene Graf, Philipp Wohlfarth, Margit Mitterbauer, Axel Schulenburg, Alexander Hauswirth, Karoline V. Gleixner, Werner Rabitsch, Peter Valent, Wolfgang R. Sperr
Journal: Blood (2024)
Efficacy and Safety of Daratumumab Combined with Bortezomib and Dexamethasone Regimen in Newly-Diagnosed Multiple Myeloma Patients
Authors: Huinan Jiang, Xianming He, Qing Leng, Miao Miao, Ming Zhang, Yingchun Li, Guojun Zhang, Jia Li, Rong Zhang, Ying Lv, Zhuogang Liu, Fei Tian, Rong Li, Wenxia Liu, Rui Zhang, Xiaohong Wang, Aijun Liao
Journal: Blood (2024)
The Prognostic Impact of Other Somatic Mutations and Cytogenetic Abnormalities in Patients with NPM1 and/or FLT3-ITD Mutated AML in the Era of FLT3-Inhibitors: Real-Life Data from the Greek AML Registry
Authors: Ioanna Lazana, Panagiotis Tsirigotis, Ioannis Konstantellos, Spiros Chondropoulos, Maria Stamouli, Konstantinos Gkirkas, Ioannis Baltadakis, Evrydiki Theodorou, Frini Karaolidou, Tatiana Tzenou, Ioanna Sakellari, Maria Papathanasiou, Chrysavgi Lalayanni, Apostolia Papalexandri, Vasiliki Violaki, Eleftheria Hatzimichael, Lydia Kyriazopoulou, Eleni Kapsali, Dora Gougopoulou, Amalia Vassou, Sofia Charalampidou, Maria Angelopoulou, Eleni Plata, Maria Papaioannou, Ioannis Vasileios Asimakopoulos, Anastasia Kopsaftopoulou, Theodoros Vassilakopoulos, Demitris Kousiafes, Theoni Leonidopoulou, Georgia Gkolfinopoulou, Panagiota Katsiampoura, Chrysanthi Vadikoliou, Theodoros Marinakis, Georgios Gkortzolidis, Eyrydiki Michalis, Maria Vardaka
Journal: Blood (2024)
Genome-Wide Association Study Identifies Novel Genetic Variants Associated with Avascular Necrosis in Sickle Cell Disease
Authors: Anna Sowa, Yue Hu, Mark T. Gladwin, Victor R. Gordeuk, Seyed Mehdi Nouraie, Yingze Zhang, Farzana D. Pashankar, Lakshmanan Krishnamurti, Jeffrey Gruen
Journal: Blood (2024)
High Efficacy of Adding G-CSF to Venetoclax Plus Azacitidine As Front-Line Treatment in Previously Untreated Acute Myeloid Leukaemia:a Pilot Study
Authors: Ting Shi, Yuan Jian, Yanru Zhang, Nian Liu, Chuanying Geng, Guorong Wang, Zhiyao Zhang, Lefu Huang, Jiajia Zhang, Yalan Zhou, Huixing Zhou, Ran Tang, Wenjing Li, Xingran Jiang, Fengyi Zhao, Wen Gao, Zhongxia Huang, Wenming Chen, Xin Li, Yun Leng, Yin Wu, Honghu Zhu
Journal: Blood (2024)
Trends in Multiple Myeloma Incidence and Mortality (1991-2021) in the United States: A Comprehensive Analysis of Gender and State-Level Disparities
Authors: Charmi Bhanushali, Vaibhavi Mukhtiar, Mansi Mehta, Vidhi Bhanushali, Clara Elizabeth Rose Cabot, Raleigh A Fatoki, Kala Seetharaman
Journal: Blood (2024)
The Impact of Liver Iron Concentration Measurements By Machine-Learned R2 Magnetic Resonance Imaging on Clinical Decision Making in a Cohort of Episodically Transfused Lebanese Patients with Sickle Cell Disease
Authors: Adlette Inati, Rita Philippe Zoghby, Avedis Mardirossian, Khaled Baroudi, Kamleh Ibrahim, Tala Elalami Elsabeh, Tim St Pierre, Leila Abas, Antoine Tarabay
Journal: Blood (2024)
Identification of Differentially Expressed Proteins As Potential Biomarkers for Diagnosis and Prognosis of Acute Myeloid Leukemia
Authors: Safa Al-Amrani, Fahad Al-Zadjali, Yasir Jeelani, Zaeema Al-Jabri, Mahdiya Pir Al Bulushi, Mohammed Al-Rawahi, Adhari Al-Zaabi, Jalila AlShekaili, Mohammed Al-Huneini, Murtadha Al-Khabori
Journal: Blood (2024)
Construction and Evaluation of a Prognostic Model for Patients with Acute Myeloid Leukemia
Authors: Feng Zhu, Yile Zhou, Yi Zhang, Wanzhuo Xie, Haitao Meng, Wenjuan Yu, Liping Mao, Jian Huang, Wenyuan Mai, Chunmei Yang, Juying Wei, Yinjun Lou, Min Yang, Jiejing Qian, Gaixiang Xu, De Zhou, Liya Ma, Xingnong Ye, Yanling Ren, Hongyan Tong, Huafeng Wang, Jie Jin
Journal: Blood (2024)
Evaluating Daratumumab Effectiveness in Relapsed/Refractory Multiple Myeloma: A Meta-Analysis of Clinical Outcomes and Prognostic Indicators
Authors: Vedant Shah, Bolivia Crocete Aloysia Fernandes, Muhammad Ashar Ali, Abhi Shah, Kaushal Patel, Aditya Mansabdar, Arya Alla, Viraj Panchal, Pramil Cheriyath
Journal: Blood (2024)
Real-World Clinical Outcomes of Daratumumab-Based Regimens in Chinese Patients with Multiple Myeloma By Cytogenetic Risk: A Subgroup Analysis of the MMY4032 Study
Authors: Luqun Wang, Wei Yang, Ting Niu, Yafei Wang, Rong Fu, Yuping Zhong, Kaiyang Ding, Kai Sun, Baijun Fang, Hong Liu, Wenbin Qian, Hui Liu, Yanhui Li, Yishen Yang, Jianmin Zhuo, Xi Chen, Canchan Cui, Jin Lu
Journal: Blood (2024)
Impact of T-Cell Redirecting Therapies on Survival Outcomes in Ultra-High-Risk Multiple Myeloma and Plasma Cell Leukemia
Authors: Hassan Elmaleh, Hong Li, Shahzad Raza, Sandra Mazzoni, Christy J. Samaras, Beth M. Faiman, Jack Khouri, Jason Valent, Faiz Anwer, Louis S Williams
Journal: Blood (2024)
Safety and Efficacy of Dara-VTD Induction and Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma Patients Presenting with Renal Failure - a Tertiary Centre UK Experience on Behalf of the UK-MRA
Authors: Adrian Maraj, Katharine Bailey, Asma Batool, Reuben Benjamin, Stella Bowcock, Kate Bramham, Madson Correia de Farias, Maria Cuadrado, Paul Donohoe, Arief Gunawan, John Jones, Majid Kazmi, Neeraj Kohli, Piers Patten, Victoria Potter, Sajitha Sachchithanantham, Matthew Streetly, Kirsty Cuthill
Journal: Blood (2024)
Characterizing Thrombotic Risk in TEMPI Syndrome: A Retrospective Case Series
Authors: Graham Blake Parker, Justin Cheng, Louis Terriou, Johanna Strobl, Ayesha Iftikhar, Davide Nappi, Meng Pan, Pierre-Yves Sansen, Elisa Diral, Elena Maria Elli, Wilfried A Schroyens, David B. Sykes, Casey L. O'Connell, Caitlin M O'Neill
Journal: Blood (2024)
Belantamab Mafodotin<i>,</i> nirogacestat and Pomalidomide for Patients with Relapsed/Refractory Multiple Myeloma
Authors: Malin Hultcrantz, Hani Hassoun, Carlyn Rose Tan, Neha Korde, Alexander M. Lesokhin, Hamza Hashmi, Kylee H Maclachlan, Sridevi Rajeeve, Urvi A. Shah, Dhwani Patel, Andriy Derkach, Selena Hamid, Tala Shekarkhand, Linh Tran, Julia Caple, Kelly Barnett, Tara Sood, Blaslov Jenna, Amanda Konsky, Kazunori Murata, Mikhail Roshal, Sergio A. Giralt, Saad Z. Usmani, Sham Mailankody
Journal: Blood (2024)
Impact of Daratumumab Refractoriness on Clinical Outcomes Following CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma
Authors: Sridevi Rajeeve, Bruno Almeida Costa, Eric M Jurgens, Noriko Nishimura, Tasmin Farzana, Ross S Firestone, Kevin Miller, Alexander M. Lesokhin, Gunjan L. Shah, Neha Korde, Carlyn Rose Tan, David J. Chung, Heather J. Landau, Michael Scordo, Hani Hassoun, Kylee H Maclachlan, Urvi A. Shah, Malin Hultcrantz, Issam S. Hamadeh, Sergio Giralt, Sham Mailankody, Saad Z. Usmani, Hamza Hashmi
Journal: Blood (2024)
Enhanced Potency of BCMA/CD19 Dual-Targeting Allogeneic CAR-T Cells for Relapsed/ Refractory Multiple Myeloma with 4-1BB/TACI Intracellular Domains
Authors: Steven Wang, Iris Pang, Claudia Chang, Michelle Burrascano, Nick DeMarco, Danny Mendoza, Sonia Reyes, Arturo Barcenas, Pastor Nieto, Jose Diaz, Garrett Arauz, Chris Lynn, Tony Nguyen, Connor Reed, Jeannette Connerney, Quy LE, Julia Coronella, Devon J Shedlock
Journal: Blood (2024)
Low/Intermediate Doses of Melphalan in the Treatment of Triple-Exposed/Refractory Multiple Myeloma: A Case Series from a Reference Center for the Treatment of Multiple Myeloma in Colombia
Authors: Humberto Martinez-Cordero, Juan-Carlos Mantilla, Jaime Valdes-Cespedes, Juan Ospina, Maria Spirko, Sebastian Alcala, Mayra Prada-Serrano, Fabian Leon-Chavez, Mario Pereira-Garzon
Journal: Blood (2024)
Comparative Efficacy of Ciltacabtagene Autoleucel Versus Elotuzumab, Isatuximab, and Selinexor-Based Regimens in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma with 1-3 Prior Lines of Therapy Using a Matching-Adjusted Indirect Comparison
Authors: Noemi Puig, Joris Diels, Suzy van Sanden, João Mendes, Teresa Hernando, Seina Lee, Nikoletta Lendvai, Nitin Patel, José Sanchez-Pina
Journal: Blood (2024)
Factors Associated with in-Hospital Mortality from Gastrointestinal Bleeding in Patients with Sickle Cell Disease
Authors: Ifeanyi Nnamdi Uche, Rohan Hehr, Henry Becerra, Shakirat Gold-Olufadi, Esther Yemisi Oluwadeyi, Mustafa Wasifuddin, Dosbai Saparov
Journal: Blood (2024)
Gender and Racial Disparities in the Impact of Factor V Leiden on Mortality and Venous Thromboembolic Outcomes Among Patients with Liver Cirrhosis: A National Inpatient Sample Analysis
Authors: Sakditad Saowapa, Natchaya Polpichai, Diego Olavarria Bernal, Hector Garcia Pleitez, Chanakarn Kanitthamniyom, Pojsakorn Danpanichkul, Chalothorn Wannaphut, Manasawee Tanariyakul, Phuuwadith Wattanachayakul, Thanathip Suenghataiphorn, Narathorn Kulthamrongsri, Ben Ponvilawan, Pharit Siladech, Lukman Tijani
Journal: Blood (2024)
Retrospective Analysis of Chemotherapy Intensity and Allogeneic Stem Cell Transplant on Patients with Myelodysplastic Syndrome Associated Acute Myeloid Leukemia - a Single Institution Experience
Authors: Osama Batayneh, Carina Hernandez, Safa Afridi, Margarita Vazquez Almonte, Daniella Passafiume, Deevyashali Parekh, Michael Sandhu, Alexandra Goodman, Angela Gupta, Sanjay Rao Gergal Gopalakrishna Rao, Josh Wallace, Teresa Gentile
Journal: Blood (2024)
Treatment of Chronic ITP with Avatrombopag: A Multicentric Real-World Experience
Authors: Mario Troiano, Claudia Giordano, Elena Rossi, Potito Rosario Scalzulli, Laura Mettivier, Alessandro D'Ambrosio, Daniele Mazzoni, Erika Vatiero, Carmine Selleri, Fabrizio Pane, Ferdinando Frigeri
Journal: Blood (2024)
The Well Tolerated VA-Based Regimen Bringing to High Quality of Life Did Not Absolutely Inferior to Intensive Chemotherapy in AML Patients with NPM1 Mutation
Authors: Wenbing Duan, Qi Chen, WenJing Yu, Jinsong Jia, Jing Wang, Xiaolu Zhu, Ting Zhao, Qian Jiang, Guorui Ruan, Xiaosu Zhao, Hongxia Shi, Ying-Jun Chang, Yu Wang, Lanping Xu, Xiaohui Zhang, Xiaojun Huang, Hao Jiang
Journal: Blood (2024)
HMA/Ven Treatment Modifications and Associated Outcomes in <i>IDH</i>-Mutant AML
Authors: Kuo-Kai Chin, Andriy Derkach, Christopher Famulare, Gaurav Gupta, Prabhakar Borge, Mark Blaine Geyer, Aaron D. Goldberg, Tamanna Haque, Jae H. Park, Lindsey Roeker, Martin S. Tallman, Maximilian Stahl, Eytan M. Stein
Journal: Blood (2024)
Unraveling <i>TP53</i>-Mutated Acute Myeloid Leukemia : Clinical Insights and Genetic Profiles
Authors: Songyi Park, Sang-A Kim, Ji Yun Lee, Ja Min Byun, Jeong-Ok Lee, Youngil Koh, Junshik Hong, Junglim Lee, Soo-Mee Bang, Inho Kim, Sung-Soo Yoon, Dongyeop Shin
Journal: Blood (2024)
Prospective Feasibility Trial of Pharmacokinetic Directed Melphalan for Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation
Authors: Charlotte FM Hughes, Andrew Lin, Maria Bromberg, Sean M. Devlin, Amethyst Saldia, Danielle E Engstler, Danielle M Hanley, Yetunde Aremu, Martin Donach, Elizabeth Hoover, Oscar B Lahoud, Arnab Ghosh, Moneeza Walji, Miguel-Angel Perales, Michael Scordo, Sergio A. Giralt, Gunjan L. Shah, Parastoo B Dahi
Journal: Blood (2024)
Utility of Early Bone Marrow Responses in <i>FLT3</i> Mutant Acute Myeloid Leukemia
Authors: Vincent Lok, Georgio Medawar, Dahniel L Sastow, Preston Perez, Su Bin Hahn, Abigail Demers, Douglas Tremblay, Alexander Coltoff, David M Swoboda
Journal: Blood (2024)
Real-World Experience with Generic Venetoclax Plus Hypomethylating Agent Induction Therapy in Newly Diagnosed Acute Myeloid Leukemia Patients in Resource-Limited Setting: A Single-Center Study from India
Authors: Arjun Kachhwaha, Reshma Benson, Paras Satadeve, Adamya Gupta, Bibhant Shah, Prisla Dalton, Kavya Ronanki, Karthik Kumar, Sashi Singh, Jhasaketan Nayak, Nikhil Nagpal, Shalini Singh, Neha Singh, Harish Chandra, Uttam Kumar Nath
Journal: Blood (2024)
Mitoxantrone Hydrochloride Liposome Combined with Cytarabine As Induction Therapy for Patients with Newly Diagnosed Secondary Acute Myeloid Leukemia
Authors: Yun Wang, Weida Wang, Jingbo Xu, Ji Ma, Hua Wang, Bingyi Wu, Yuanbin Song, Weiran Lv, Lezong Chen, Jun Ma, Tiejun Gong, Yang Liang
Journal: Blood (2024)
Could It be Vexas? Considering This Rare Disease Based on Hematological Findings
Authors: Lyam Carlo Chacon Rangel, Eduardo Martin-Nares, Beatriz Sánchez-Hernández, David Solar Cafaggi, Daniel Montante-Montes de Oca, Sayetzi Rico-Sánchez, Elia Ixel Apodaca Chavez, Alvaro Aguayo
Journal: Blood (2024)
Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial
Authors: Daniel H. Palmer, Richard Jackson, Christoph Springfeld, Paula Ghaneh, Charlotte Rawcliffe, Christopher M. Halloran, Olusola Faluyi, David Cunningham, Jonathan Wadsley, Suzanne Darby, Tim Meyer, Roopinder Gillmore, Pehr Lind, Bengt Glimelius, Stephen Falk, Yuk Ting Ma, Gary William Middleton, Sebastian Cummins, Paul J. Ross, Harpreet Wasan, Alec McDonald, Tom Crosby, Pascal Hammel, David Borg, Sharmila Sothi, Juan W. Valle, Arianeb Mehrabi, Peter Bailey, Christine Tjaden, Christoph Michalski, Thilo Hackert, Markus W. Büchler, John P. Neoptolemos
Journal: Journal of Clinical Oncology (2024)

PURPOSE The ESPAC4 trial showed that adjuvant chemotherapy with gemcitabine plus capecitabine (GemCap) produced longer overall survival (OS) than gemcitabine monotherapy. Subsequently, the PRODIGE24-CCTG PA.6 trial showed even longer survival for modified fluorouracil, folinic acid, irinotecan, and oxaliplatin (mFOLFIRINOX) than gemcitabine but had more restrictive eligibility criteria. Our aim was to analyze the ESPAC4 survival on long-term follow-up. METHODS The OS of 732 ESPAC4 patients comparing 367 randomly assigned to gemcitabine and 365 to GemCap was previously reported after a median follow-up time of 43.2 months (95% CI, 39.7 to 45.5) and 458 deaths. Analysis was now carried out after a median follow-up of 104 months (101-108) and 566 deaths. RESULTS The median OS was 29.5 months (27.5-32.1) for all patients, 28.4 months (25.2-32.0) in the gemcitabine group and 31.6 months (26.5-38.0) in the GemCap group (hazard ratio [HR], 0.83 [0.71 to 0.98]; P = .031). R0 patients given gemcitabine had a median survival of 32.2 months (27.9-41.6) compared with 49.9 months (39.0-82.3) for those given GemCap (HR, 0.63 [0.47 to 0.84]; P = .002). Lymph node-negative patients had significantly higher 5 year OS rates on GemCap (59% [49%-71%]) than gemcitabine (53% [42%-66%]; HR, 0.63 [0.41 to 0.98]; P = .04) but not those with positive lymph nodes ( P = .225). The OS advantage for GemCap was retained in the PRODIGE24 subgroup of 193 (26.4%) ESPAC4 patients not eligible for PRODIGE24 with a median survival of 20.7 (16.2-27.3) months in patients allocated to gemcitabine compared with 25.9 (22.3-30.2) months for ineligible patients allocated to GemCap (HR, 0.71 [95% CI, 0.52 to 0.98]; χ 2 log-rank-1df = 4.31; P = .038). CONCLUSION GemCap is a standard option for patients not eligible for mFOLFIRINOX. Exploratory evidence suggests that GemCap may be particularly efficacious in R0 patients and also in lymph node-negative patients.
Real-World Evidence of Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, Lenalidomide with or without Polatuzumab (VIPOR(P)) for Relapsed/Refractory Large B-Cell Lymphoma
Authors: Rebecca Wurm-Kuczera, Khouloud Kouidri, Meng Wang, Salahedine Ali, Shashwat Sahay, David Winkler, Ann-Kristin Leskien, Samixa Pudasaini, Joseph Kauer, Isabelle Krämer, Marcel Teichert, Niklas Gebauer, Ulf Schnetzke, Thomas Weber, Lukas Peter Frenzel, Anna-Carina Hund, Evgenii Shumilov, Mirjeta Berisha, Jakob Daniel Rudzki, Christian W. Scholz, Dimitrios Mougiakakos, Georg Lenz, Gerald Wulf, Martin Schmidt-Hieber, Bastian von Tresckow, Peter Dreger, Martin Dreyling, Oliver Weigert, Naveed Ishaque, Ulrich Keller, Christiane Pott, Thomas Oellerich, Björn Chapuy
Journal: Blood (2024)
Venetoclax, Azacitidine, Vorinostat and FLAG for Pediatric Patients with Relapsed/Refractory Acute Myeloid Leukemia
Authors: Zachary Graff, Amy Pan, Liyun Zhang, Nathan Gossai, Christeen Azmy, Amberley Kemic, Alyssa Frelka, Michael J. Burke
Journal: Blood (2024)
A Novel Clinical Trial in Rare Paediatric B-Cell Non-Hodgkin Lymphoma: Evaluating the Glo-Bnhl Adaptive Bayesian Design Using Data from the Sparkle Trial
Authors: Shanna Maycock, Rui Qin, Emma Seaford, Anna Lawson, Ellie Williams, Joseph Rogers, Zahra Ahmed, Mahnoor Muzaffar, Rhianna Parsons, Sanjay Deshpande, Gladstone Austin Amos Burke, Lucinda Billingham
Journal: Blood (2024)
Uncovering Therapeutic Vulnerabilities in Adverse-Risk Pediatric Acute Myeloid Leukemia
Authors: Sabrina Halim, Noémie Sultan, Sophie Cardin, Verena Gress, Billy Ta, Nehme El-Hachem, Emma Rose Cheetham, Carolina Marmolejo, Anne-Cécile Soufflet, Louise Laramée, Melanie Bilodeau, Vincent-Philippe Lavallee, Catherine Goudie, Henrique Bittencourt, Brian T. Wilhelm, Frederic Barabe, Josée Hébert, Sonia Cellot
Journal: Blood (2024)
Decitabine Synergizes with Replication Checkpoint Inhibitors in <i>TP53</i>-Mutated Acute Myeloid Leukemia
Authors: Clifford M. Csizmar, Antoine N. Saliba, Kevin L. Peterson, Xue Wei Meng, B. Douglas Smith, Gabriel Ghiaur, Mrinal M. Patnaik, Scott H. Kaufmann
Journal: Blood (2024)
Impact of FLT3-ITD Molecular Characteristics on the Prognosis of Patients with De Novo Acute Myeloid Leukemia
Authors: Kainan Zhang, Xiaohang Ma, Xiaoxuan Lu, Guo-rui Ruan, Fangfang Wei, Hao Jiang, Xiao Jun Huang, Xiaosu Zhao
Journal: Blood (2024)
Fast pH-Driven Solubilization Method of Realgar (As4S4) to Reduce the Toxicity of Arsenic [As(III)] for Therapeutic Use Against Acute Promyelocytic Leukemia and HIV
Authors: Bojana Lucic, Douglas Santana Franciscato, Marli Curcio, Helton Pereira Nogueira, Lara Gallucci, Alceu Totti Silveira Junior, Asma Ismail, Millie Robinson, Teresa Dallinger, Maytê Toledo, Jessica Dias, Mohammad Tarek, Danilo Dias, Ricardo Sobhie Diaz, Mahmoud ElHefnawi, Mattia Forcato, Hugo Monteiro, Marina Lusic, Iart Luca Shutaj, Andrea Savarino
Journal: Blood (2024)
Concurrent Coronary Artery Disease and Immune Thrombocytopenia: A Systematic Review
Authors: Waail Rozi, Alaa Rahhal, Drew Provan, Khaled Shunnar, Mostafa Najim, Ashraf Ahmed, Murtadha Al-Khabori, Mahmoud Marashi, Mona Alrasheed, Hani Yousif Osman, Mohamed A Yassin
Journal: Blood (2024)
Multicenter Real-World Use of Polatuzumab Vedotin in Diffuse Large B-Cell Lymphoma(DLBCL) of Frontline and Relapse/Refractory Settings in China
Authors: Zhangyuting He, Huiying Zhu, Chong Wei, Danqing Zhao, Wei Wang, Jian Li, Wei Zhang, Daobin Zhou, Yan Zhang
Journal: Blood (2024)
Space Disinfection Using TiO2 Photocatalyst Reduces the Incidence of Febrile Neutropenia in Cancer Patients
Authors: Kazuhide Iizuka, Heihachiro Ochiai, Yoshikazu Iizuka, Junichi Somei, Katsuhiro Miura, Hideki Nakamura, Tomohiro Nakayama, Yoshihiro Hatta, Masami Takei
Journal: Blood (2024)
Triple-Drug Regimen for Naïve MDS and AML Patients: Efficacy and Safety of Chidamide, Azacitidine, and Venetoclax in a Prospective Multicenter Study
Authors: Min Zhang, Miaomiao Zhao, Renying Ge, Xie-Na Cao, Mei Xue, Jing He, Zhaodong Zhong, Xin Fu
Journal: Blood (2024)
Phase 1 Study of ARV-393, a PROTAC BCL6 Degrader, in Advanced Non-Hodgkin Lymphoma
Authors: Paolo F. Caimi, Scott F Huntington, Sean Landrette, Sheryl M Gough, Vivian Dai, Bryan Jackson, Tinghui Yu, Juan Chavez, Sarah Tannenbaum-Dvir, Matthew Matasar
Journal: Blood (2024)
Mitoxantrone Hydrochloride Liposome (Lipo-MIT) Combined with R-GDP Regimen in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Multicenter, Single-Arm Study
Authors: Li Ma, Jin Zhao, Jingrong Wang, Meijing Zheng, Xiaolian Wen, Junyuan Lang, Bin Yang, Liping Su
Journal: Blood (2024)
Effect of <i>NPM1</i> mutation Subtype and Co-Mutation Patterns on the Outcomes of Patients with Acute Myeloid Leukemia; A Referral Center Experience
Authors: Ratdanai Yodsuwan, Sarah L Mott, Kathryn Crawford, Grerk Sutamtewagul, Prajwal Dhakal, Margarida Magalhaes-Silverman, Kittika Poonsombudlert
Journal: Blood (2024)
Outcomes of Outpatient CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Relapsed or Refractory B-Cell Lymphomas: A Systematic Review and Meta-Analysis
Authors: Moazzam Shahzad, Jawad Noor, Muhammad Kashif Amin, Zubia Zaman, Umar Akram, Maryyam Sharif, Hameer Ali, Uzma Qayyum, Muhammad Waqas Khan, Sheena Shamoon, Bidushi Pokhrel, Asim Ahmad Khan, Hira Habib, Sibgha Gull Chaudhary, Iqra Anwar, Forat Lutfi, Leyla O. Shune, Joseph P. McGuirk, Muhammad Umair Mushtaq
Journal: Blood (2024)
<i>Comparative Retrospective Study of Therapies and Trends for Hospitalized Patients with New-Onset Immune Thrombocytopenia</i>
Authors: Emily Grace Sherry, Sophia Lee, Michael Auster, Raed Benkhadra, Miguel Ocampo, Abhishek Pandya, Anand Karnad, Elizabeth Bowhay-Carnes
Journal: Blood (2024)
Mitoxantrone Hydrochloride Liposome (Lipo-MIT) Combined with Azacitidine and Chidamide Can be an Effective Chemotherapy Regimen for Patients with Angioimmunoblastic T-Cell Lymphoma (AITL)
Authors: Yanli Wang, Li Lang, Li Ma, Jingrong Wang, Shaohua Wu, Min Bai, Xuliang Shen, Xiaolian Wen, Le Li, Liping Su
Journal: Blood (2024)
A Phase II Study of Dual Epigenetic Agents Plus Obinutuzumab-Mitoxantrone Liposome in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients Failure of Salvage Immunochemotherapy
Authors: Changju Qu, Nana Ping, Rui Zou, Jiajie He, Qian Zhu, Xiao Zhang, Junhong Li, Fan Xia, Lingzi Yu, Depei Wu, Zhengming Jin
Journal: Blood (2024)
Clinical and Genetic Study of Hereditary Spherocytosis in the Spanish Population
Authors: Lucia Castilla Garcia, Jose Aspa-Cilleruelo, Jorge Martínez Nieto, Angel Zúñiga-cabrera, Rafael Andrés Del Orbe Barreto, Ricard Sanchez, Rosa Ayala, ANA Garcia Feria, Julio Dávila-Valls, Cristina Jativa saez, Josefa Esperanza Marco Buades, Fernando Ataulfo Gonzalez Fernandez, Ana Villegas, Montserrat López Rubio
Journal: Blood (2024)
Mecapegfilgrastim for Preventing Chemotherapy-Induced Neutropenia in Patients with Diffuse Large B-Cell Lymphoma: A Multicenter, Open-Label, Randomized Controlled Trial
Authors: Jie Wang, He LI, Qiaochu Lin, Kun Yang, Chunrong Ma, Hong Zhai, Jin Wei, Yan Zuo, Jie Zhou, Ting Niu
Journal: Blood (2024)
Polatuzumab Vedotin Plus Anti-CD20 Monoclonal Antibody and Dexamethasone in Previously Untreated Very Old/Frail Patients with Diffuse Large B-Cell Lymphoma
Authors: Xiaoya Yun, Jiefei Bai, Ru Feng, Jiangtao Li, Ting Wang, Yazi Yang, Jingjing Yin, Long Qian, Weidong Ding, Xiaoxuan Xue, Haoyu Qin, Hongmei Jing, Hui Liu
Journal: Blood (2024)
A Prospective Clinical Study of Zanubrutinib Combined with R-CHOP Regimen in the Treatment of Newly Diagnosed Double Expression Diffuse Large B-Cell Lymphoma
Authors: Yingying Wu, Ao Zhang, Liling Zhang, Guohui Cui, Fang Liu, Zhichao Chen, Zhipeng Chen, Lu Zhang, Lin Liu, Wenjuan He, Yu Hu, Linghui Xia, Jun Fang
Journal: Blood (2024)
Two Decade Single Institution Experience Highlights Rare Survivors with Relapsed or Refractory Burkitt Lymphoma
Authors: Rabeya Molla, Ellin Berman, Philip Caron, Gerard Donnelly, Lorenzo Falchi, Paul A. Hamlin, Steven Horwitz, Andrew M. Intlekofer, William T. Johnson, Joseph G Jurcic, Anita Kumar, Jennifer Kimberly Lue, Alison Moskowitz, Colette Owens, Parastoo B Dahi, Maria Lia Palomba, Carol S. Portlock, Gilles Salles, Craig S Sauter, Santosha A. Vardhana, Gunjan L. Shah, David J. Straus, Anas Younes, Anas Younes, Andrew D. Zelenetz, Ariela Noy
Journal: Blood (2024)